Prestigious Research Grant from NINDS
iPACES LLC Receives Prestigious Research Grant from the National Institute of Neurological Disorders and Stroke (NINDS) a division of NIH (National Institutes of Health).
iPACES™ is a neuro-exergame to impact brain health and wellness via a portable pedal-and-play technology designed for everyday use, including for patients and caregivers coping with challenges, from autism to Alzheimer's

iPACES LLC is developing an innovative solution to support brain health through combined physical and cognitive exercise. Our system, called iPACES (the interactive Physical and Cognitive Exercise System), is a “pedal-n-play” neuro-exergame designed to address cognitive challenges associated with a wide range of neurological conditions, from autism to Alzheimer’s disease. Research on iPACES as a prescriptive digital therapeutic (PdTx) has been supported by the National Institutes of Health (NIH), with a primary focus on improving cognition in older adults with mild cognitive impairment (MCI). As dementia cases continue to rise and no cure yet exists, behavioral interventions such as exercise have gained increasing attention for their ability to enhance brain health and help prevent or slow cognitive decline.
iPACES LLC continues to advance neuro-exergaming as a behavioral intervention for preventing and remediating cognitive decline from Alzheimer’s disease and related dementias (ADRDs), as well as for individuals with Parkinson’s disease (PD). The current (2025–2027) randomized clinical trial (RCT) of iPACES for Parkinson’s is funded by the NIH’s National Institute of Neurological Disorders and Stroke (NINDS) through the Small Business Innovation Research (SBIR) program. It is run from three sites: one in the Capital District area of Albany, NY; one on the North Shore of Boston, MA; and one in the greater Los Angeles region, CA. This trial aims to maximize the cognitive benefits of long-term exercise by integrating tailored mental challenges with physical activity, targeting specific cognitive difficulties experienced by people with Parkinson’s.
The iPACES software is designed to be flexible — researchers can adjust in-app challenge levels and cognitive task settings to match each participant’s cognitive ability and study condition. The system supports a bring-your-own-device (BYOD) model, allowing participants to use their own smartphone or tablet with any recumbent pedaler, whether at home or in a community gym. Digital features such as virtual coaching, engaging visual environments, in-game rewards, notifications, and remote data collection via smartphones and wearable devices (e.g., smartwatches) help promote engagement and adherence.
Participants in our current studies engage with iPACES three to five times per week for one year. Our studies compare cognitive and biomarker outcomes across multiple time points, examining the effects of different intensities and types of mental exercise. Following investigation, iPACES LLC plans to prepare results for scientific publication and, pending FDA review, pursue commercialization of iPACES as an empirically supported, prescriptible digital therapeutic (PdTx). The goal is to make iPACES available as a clinically validated tool that physicians and healthcare providers can use to support cognitive health in neurological conditions.

Neuropsychologist

Applied Physiology and Nutrition Scientist

COO

1st Playable
Prestigious Research Grant from NINDS
iPACES LLC Receives Prestigious Research Grant from the National Institute of Neurological Disorders and Stroke (NINDS) a division of NIH (National Institutes of Health).
Providence
New study examines effects of simultaneous physical and cognitive exercise on brain health
Bizwomen: The Business Journals
'Exergame' startup targets cognitive decline
Can’t find the answer you’re looking for? Reach out to us at info@myipaces.org
iPACES is developing a neuro-exergame for use in clinical research.
Our current study is a completely remote study.
No, we provide it to you free of charge.
iPACES principals have been published in leading scientific journals and publications in recent years.